# Toripalimab With Chemotherapy for Sinus Cancer

> **NCT06940180** · PHASE2 · RECRUITING · sponsor: **Glenn J. Hanna** · enrollment: 20 (estimated)

## Conditions studied

- Sinonasal Cancer
- Paranasal Sinus Neoplasms
- Squamous Cell Carcinoma
- Sinonasal Undifferentiated Carcinoma
- Locally Advanced Head and Neck Cancer

## Interventions

- **DRUG:** Toripalimab
- **DRUG:** Carboplatin
- **DRUG:** Docetaxel
- **RADIATION:** Radiation Therapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT06940180
- **Lead sponsor:** Glenn J. Hanna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-17
- **Primary completion:** 2028-02-01
- **Final completion:** 2029-02-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940180, "Toripalimab With Chemotherapy for Sinus Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06940180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*